Pharmaceutical firm Shionogi & Co. Ltd has entered the European community with the opening of a new London office.
The office will act as a European headquarters for the Japanese-based firm. Shionogi took the decision to use London as a base following an extensive period of research into potential locations both in and outside of the United Kingdom.
CEO of Shionogi Europe, Takashi Takenoshita, commented on the opening of the new office.
He said: “We are delighted to be launching our new European headquarters in London.
“We aim to achieve our mission as a company with a strong presence in Europe, which conducts business operations recognised by patients, their families, healthcare providers and broader communities,” Mr Takenoshita concluded.
Mayor of London, Boris Johnson, stated: “Boosting jobs and growth is my number one priority, and this means attracting ever more companies to the capital. Shionogi will make a fantastic addition to London’s growing life sciences sector, which benefits from our top class universities and research centres, direct access to huge markets, a skilled cosmopolitan workforce and fantastic connectivity.
“London really is the best place in the world to do business, something I will be taking every opportunity to showcase throughout this summer like no other.”
News bought to you from DeVono Cresa, the award-winning commercial property advisers, specialising in Central London office, retail and leisure space.